Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease.
Johan BurischHe ZhangCasey Kar-Chan ChoongDavid NelsonApril NaegeliTheresa GibbleIris GoetzAlexander EgebergPublished in: Therapeutic advances in gastroenterology (2021)
Administrative claims data can be useful for identifying patients exhibiting (F-calprotectin defined) flare-ups of their IBD. Clinically relevant events captured in the Danish national patient registry are associated with increased levels of calprotectin and hence increased disease activity, and can be used as valid outcomes in future studies.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- ankylosing spondylitis
- end stage renal disease
- health insurance
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- case report
- current status
- type diabetes
- quality improvement
- metabolic syndrome
- machine learning
- artificial intelligence
- ulcerative colitis